Sandy Draper
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
125
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $319.56 | +35.19% | 12 | Jul 24, 2024 | |
| ACCD Accolade | Maintains: Buy | $13 → $6 | $3.20 | +87.50% | 5 | Jun 28, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $209.16 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $180.96 | - | 15 | Feb 15, 2024 | |
| EVH Evolent Health | Maintains: Hold | $36 → $34 | $23.46 | +44.93% | 9 | Nov 14, 2023 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $6.19 | +61.55% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $42.35 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $0.30 | +566.89% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $220.40 | +19.33% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $2.70 | +1,011.11% | 3 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $89 → $94 | $86.33 | +8.88% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $9.21 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $18.99 | +168.56% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $124.16 | +3.90% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $34.31 | +60.30% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $69.80 | +140.69% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $20.36 | -41.06% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $180 | $0.90 | +19,902.22% | 1 | Mar 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $33 → $38 | $20.28 | +87.38% | 7 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $5.09 | +882.32% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $14.00 | +364.29% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $7.70 | +367.53% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $212.78 | -21.52% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.75 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $15.57 | +304.62% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $319.56
Upside: +35.19%
Accolade
Jun 28, 2024
Maintains: Buy
Price Target: $13 → $6
Current: $3.20
Upside: +87.50%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $209.16
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $180.96
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36 → $34
Current: $23.46
Upside: +44.93%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $6.19
Upside: +61.55%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $42.35
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $0.30
Upside: +566.89%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $220.40
Upside: +19.33%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $2.70
Upside: +1,011.11%
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $86.33
Upside: +8.88%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $9.21
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $18.99
Upside: +168.56%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $124.16
Upside: +3.90%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $34.31
Upside: +60.30%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $69.80
Upside: +140.69%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $20.36
Upside: -41.06%
Mar 29, 2021
Initiates: Buy
Price Target: $180
Current: $0.90
Upside: +19,902.22%
Feb 4, 2021
Maintains: Hold
Price Target: $33 → $38
Current: $20.28
Upside: +87.38%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $5.09
Upside: +882.32%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $14.00
Upside: +364.29%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $7.70
Upside: +367.53%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $212.78
Upside: -21.52%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.75
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $15.57
Upside: +304.62%